• london biotech banner
  • Dermatology June 24 Conference
MedEdge MEA MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
Reading: Avalon Pharma to float on Saudi Exchange’s main market
Share
Notification
  • london biotech banner
  • Dermatology June 24 Conference
MedEdge MEA
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
Have an existing account? Sign In
MedEdge MEA > News > Avalon Pharma to float on Saudi Exchange’s main market
NewsLead

Avalon Pharma to float on Saudi Exchange’s main market

ME Web Desk
Web Desk
Published: January 8, 2024
Share
2 Min Read
Avalon Pharma to float on Saudi Exchange's main market
SHARE

Riyadh, Saudi Arabia- January 2024- One of the Kingdom of Saudi Arabia’s fastest-growing domestic pharmaceutical manufacturing firms, Middle East Pharmaceutical Industries Company, Avalon Pharma, has announced its plan to move forward with an IPO and list its common shares on the Saudi Exchange’s Main Market.

The Capital Market Authority accepted the company’s request on December 6, 2023, to offer 6,000,000 shares through the sale of current shares by selling shareholders, which amounts to 30% of the company’s issued share capital. After the book-building period, which runs from Sunday, January 14, 2024, through Thursday, January 18, 2024, is over, the final offer price of the Offer Shares will be decided.

Commenting on the Intention to Float, Ahmed Tabbaa, Founder and Chairman of Avalon Pharma said “When I look back on the journey of our business over the last 25 years, I am delighted with the progress that we have made in becoming a leading consumer pharmaceutical company in the Kingdom of Saudi Arabia. We are a true success story within the Kingdom, having developed and expanded significantly during this time, venturing into new areas and products as we have adapted to, and anticipated, market demand. In listing on the Saudi Exchange, we are now able to capture future growth and provide an opportunity for a greater number of stakeholders to share in our success.”

Also Read: These four Saudi Arabian hospitals are “Baby Friendly”

Mohammed Maher AlGhannam, MD & CEO of Avalon Pharma, added “Since its foundation, the Company has built a reputation through the quality of its products and as one of the fastest-growing pharmaceutical companies in Saudi Arabia. The market within the Kingdom is changing rapidly and we are well placed to capture future growth across the region as we have shown over the years through our ability to address the market needs.”

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article https://mededgemea.com/abbotts-strategic-partnership-with-mabxience-boosts-access-to-oncology-and-womens-health-biosimilars-in-emerging-markets/ Mark Your Calendar: Abbott Q4 Earnings Call Coming Soon?
Next Article constipation Constipation: Causes, Solutions, and Impact on Public Health

Recent Posts

  • Abu Dhabi DoH Shuts Down Four Clinics in Major Sick Leave Fraud Case
  • Spike in Bird Flu Among Cats Raises Concerns About Human Spillover
  • Childhood Diet May Determine When Girls Begin Puberty, Study Finds
  • smart and American University of Sharjah (AUS) Raise AED 10,000 Through Walkathon for Scholarships
  • The View Hospital Becomes Qatar’s First to Earn JCI 8th Edition Accreditation
  • Dermatology expo rome
  • LifeSpin
Two Point Five Logo white
  • About Us
  • Terms and Conditions
  • Privacy Policy
  • Submit Your Story
  • Contact Us
  • MediaKit
Reading: Avalon Pharma to float on Saudi Exchange’s main market
Share

Published by Two Point Five Media FZCO

  • About Us
  • Terms and Conditions
  • Privacy Policy
  • Submit Your Story
  • Contact Us
  • MediaKit
Reading: Avalon Pharma to float on Saudi Exchange’s main market
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?